The Patent Finder

Terms ending in 2033

Gilead Sciences, Inc.

Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,284,323Naphthalene Acetic Acid Derivatives Against HIV Infection
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 9,376,3922- (TERT - Butoxy) -2- (7 -Methylquinolin- 6 - Yl) Acetic Acid Derivatives for Treating Aids
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 8,742,126Apoptosis Signal-Regulating Kinase Inhibitor
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 9,254,284Apoptosis Signal-Regulating Kinase Inhibitor
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 9,333,197Apoptosis Signal-Regulating Kinase Inhibitor
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 9,750,730Apoptosis Signal-Regulating Kinase Inhibitor
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 9,873,682Apoptosis Signal-Regulating Kinase Inhibitor
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 10,508,100Apoptosis Signal-Regulating Kinase Inhibitor
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,962,610Fused Heterocyclic Compounds as Ion Channel Modulators
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 9,988,425Immunogens for HIV Vaccination
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
47 more term ends in 2033 · Pro
10 of 57 patents shown. Soonest term end first, then patent number.
Pro members see all 57.
Upgrade to Pro
50 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited